Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs Bristol Myers Squibb announced positive topline results from the planned interim analysis of the ACTION-1 trial…
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP TriLink BioTechnologies, LLC a Maravai LifeSciences company and global provider of life science reagents and services, announced it has been granted a…
As Tariffs Reshape the Molded Fiber Market, Yangi Brings Its Dry-Forming Technology Cellera® to U.S. Converters Yangi, the Swedish developer of Cellera®, a dry-forming technology for fiber-based packaging, is entering the U.S. market with its quick-serve packaging range, as part of…
Maxis AI Introduces the First Verticalized Context Layer for Life Sciences, a Governed Execution Fabric That Makes Enterprise AI Reliable, Cost-Efficient, and Regulatory Compliant Maxis AI introduced MaxisAI Holarchy, its Verticalized Context Layer, a governed institutional memory that gives life sciences…
American Chemical Society Names Syngenta’s Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals Camilla Corsi, Head of Crop Protection Research & Development at Syngenta, is the winner of the prestigious 2026 American Chemical Society (ACS)…
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline Glucotrack announced the continued expansion of the ai² Futures Lab™ operated through its wholly owned subsidiary, Lōkahi Therapeutics™ Inc. During its first year, the ai² Futures Lab™ identified more than 45…
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026 Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association…
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI MindWalk Holdings Corp. a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s…
Wiley Joins U.S. Department of Energy’s Genesis Mission Consortium to Advance AI-Powered Scientific Discovery Wiley announced its membership in the Genesis Mission Consortium, the public-private partnership supporting the U.S. Department of Energy’s (DOE) Genesis Mission, joining organizations including Nvidia, AWS,…
illumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer Surgery illumiSonics Inc., a medical technology company commercializing label-free tissue imaging, announced the launch of a prospective clinical validation study at Sunnybrook Health…
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA Bristol Myers Squibb a global biopharmaceutical leader, announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72…
ZEISS Meditec Selects Atlas® System from Nirrin Technologies to Modernize Hyaluronic Acid Manufacturing Workflows Nirrin Technologies, a developer of analytical tools designed to transform bioprocess analytics, announced that Hyaltech, a Carl ZEISS Meditec (CZM) company has purchased an Atlas® system to support…